2019
DOI: 10.1590/1414-431x20187517
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of the application values of different combination schemes of liquid-based cytology and high-risk human papilloma virus test in the screening of high-grade cervical lesions

Abstract: The aim of this study was to explore the value of different combination schemes of liquid-based cytology (LBC) and high-risk human papilloma virus (HPV) test in the screening of high-grade (≥CIN 2) cervical lesions. From 5727 women who had undergone examinations with LBC and high-risk HPV test, 1884 patients with positive results of either or both LBC and HPV test were included in this study and underwent cervical biopsy. Based on the pathological examination results, comparisons of the assessment indicators o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Ranking as the second most common cancer in the female reproductive system, cervical cancer still manifests high morbidity and mortality in developing countries including China, imposing a strong impact on the body health and quality of life of women 1 . Fortunately, studies have demonstrated that high-risk human papillomavirus (HPV) infection can be the definite etiology of cervical cancer [2][3][4][5] , making it possible to detect 80.7-98.7% of cervical intraepithelial neoplasia (CIN) early through screening combined with HPV testing and cytology [6][7][8] . As the gold standard for diagnosing cervical cancer and its precancerous lesions, colposcopy-guided biopsies play a key role in the early detection of cervical cancer.…”
mentioning
confidence: 99%
“…Ranking as the second most common cancer in the female reproductive system, cervical cancer still manifests high morbidity and mortality in developing countries including China, imposing a strong impact on the body health and quality of life of women 1 . Fortunately, studies have demonstrated that high-risk human papillomavirus (HPV) infection can be the definite etiology of cervical cancer [2][3][4][5] , making it possible to detect 80.7-98.7% of cervical intraepithelial neoplasia (CIN) early through screening combined with HPV testing and cytology [6][7][8] . As the gold standard for diagnosing cervical cancer and its precancerous lesions, colposcopy-guided biopsies play a key role in the early detection of cervical cancer.…”
mentioning
confidence: 99%
“…Extensive research confirms high-risk human papillomavirus infection as a primary cause of cervical cancer [12,17,8,25]. Early screening, when paired with HPV testing and cytology, has the potential to identify 80.7-98.7% of cervical intraepithelial neoplasia [26,3]. Colposcopy-guided biopsies are the gold standard for detecting cervical cancer and its precancerous lesions.…”
Section: Introductionmentioning
confidence: 99%